Volume 10, Issue s2, July 2008
Review Articles
Optimum management of type 2 diabetes timely introduction, optimization and intensification of basal insulin
G. Dailey
pages 5–13
Reaching glycaemic targets while minimizing hypoglycaemia in insulin-treated type 2 diabetes patients
C. Mathieu S. Robbrecht
pages 14–23
Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience
S. A. Schreiber
pages 24–34
Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine
H. U. Janka
pages 35–41
Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine
M. Davies K. Khunti
pages 42–49
Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine
C. Bradley C. J. B. Gilbride
pages 50–65
The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics
P. Levin
pages 66–75
Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus
D. Raccah
pages 76–82
Beyond insulin replacement: addressing the additional needs of the diabetes patient
G. Dailey
pages 83–97
The publication of this supplement has been supported by an unrestricted educational grant from sanofi-aventis.
This week's Diabetes Bulletin...
...
No comments:
Post a Comment